Antineoplastic chemotherapy of the older cancer patient

Hematology/Oncology Clinics of North America

Volumn 14, Issue 1, 2000, Pages 193-212

  Balducci, Lodovico ^a,b   Corcoran, Mary Beth ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CLADRIBINE; CYTARABINE; DACARBAZINE; FLUDARABINE; HYDROXYUREA; IDARUBICIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE;

AGED; AGING; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; FEBRILE NEUTROPENIA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 0033966091     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70284-7     Document Type: Article

References (93)

1. A. Allen The cardiotoxicity of chemotherapeutic drugs Semin Oncol 19 1992 529 542
2. American Society of Clinical Oncology Recommendations for the use of hemopoietic colony-stimulating factors: Evidence-based clinical practice guidelines J Clin Oncol 12 1994 2471 2508
3. J.O. Armitage J.F. Potter Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly J Am Geriatr Soc 32 1984 269 273
4. S.D. Baker L. Grochow Pharmacology of cancer: Chemotherapy in the older person Clin Geriatr Med 13 1997 169 183
5. L. Balducci M. Extermann Cancer and aging: An evolving panorama Hematol Oncol Clin North Am 14 2000 1 16
6. L. Balducci M. Extermann Cancer chemotherapy in the older patient: What the medical oncologist needs to know Cancer 80 1997 1317 1322
7. L. Balducci C.H. Hardy Anemia of aging: A model of cancer-related anemia Cancer Control JHLMCC 5 suppl 1998 17 21
8. L. Balducci D.M. Phillips K.M. Davis Systemic treatment of advanced cancer in the elderly Arch Gerontol Ger 7 1988 119 150
9. L. Balducci G. Stanta Cancer in the frail patient: A coming epidemic Hematol Oncol Clin North Am 14 2000 235 250
10. C.A. Baraldi-Junkins A.C. Beck G. Rothstein Hematopoiesis and cytokines: Relevance to cancer and aging Hematol Oncol Clin North Am 14 2000 45 61
11. Y. Bastion J.-Y. Blay M. Divine Elderly patients with aggressive non-Hodgkin's lymphoma: Disease presentation, response to treatment and survival. A Groupe d'Etude des Lymphomes de l'Adulte Study on 453 patients older than 69 years J Clin Oncol 15 1997 2945 2953
12. M. Bertini R. Freilone U. Vitolo The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: Feasibility and efficacy of an intensive multidrug regimen Leuk Lymphoma 22 1996 483 493
13. A. Bonetti T. Franceschi G. Apostoli Cisplatin pharmacokinetics in elderly patients Ther Drug Monit 16 1994 477 482
14. J.M. Borkowski M. Duerr R.C. Donehower Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetics data Cancer Chemother Pharmacol 33 1994 493 496
15. T. Buchner Treatment of acute myeloid leukemia in the older patient L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 545 550
16. G.S. Chatta T.H. Price R.C. Allen Effects of “in vivo” recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers Blood 84 1994 2923 2929
17. K. Christman H.B. Muss D. Case Chemotherapy of metastatic breast cancer in the elderly JAMA 268 1992 57 62
18. J.F. Cleary Cancer pain in the elderly L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 753 764
19. C.S. Cleeland G.D. Demetri J. Glaspy Identifying hemoglobin levels for optimal Quality of Life. Results of an incremental analysis [abstract 2215] Proceedings of the American Society of Clinical Oncology 16 1999 574a
20. M.B. Corcoran Polypharmacy in the older patient L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 525 532
21. D. Cova G. Beretta L. Balducci Cancer chemotherapy in the older patients L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 429 442
22. K.E. Covinsky E. Kahana M.H. Chin Depressive symptoms and three year mortality in older hospitalized medical patients Ann Intern Med 130 1999 563 569
23. P. Crome R.J. Flanagan Pharmacokinetic studies in elderly people Clin Pharmacokinet 26 1994 243 247
24. M.G. Daidone A. Luisi R. Silvestrini Biologic characteristics of primary breast cancer in the elderly L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 197 200
25. Del mastro L. M. Venturini R. Lionetto Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia J Clin Oncol 15 1997 2715 2721
26. G.D. Demetri M. Kris J. Wade Quality of life benefit in chemotherapy patients treated with epoietin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group J Clin Oncol 16 1998 3412 3425
27. E. Diaz-Rubio J. Sastre A. Abad UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients Oncology (Huntingt) 13 suppl 3 1999 35 40
28. J.H. Doroshow Anthracyclines and anthracendiones B.A. Chabner Longo D.I. Cancer Chemotherapy and Biotherapy 1996 Lippincott-Raven Philadelphia 409 434
29. E.H. Duthie Physiology of aging: Relevance to symptoms, perceptions, and treatment tolerance L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 247 262
30. J.M. Eagles J.A.G. Beattie D.B. Restall Relationship between cognitive impairment and early death in the elderly BMJ 300 1990 239 240
31. M. Extermann Acute leukemia in the elderly Clin Geriatr Med 13 1997 227 244
32. M. Extermann Assessment of the older cancer patient Hematol Oncol Clin North Am 14 2000 63 77
33. D.E. Fisher Apoptosis, chemotherapy and aging L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 237 246
34. J.L. Gabrilove L.H. Einhorn R.B. Livingston Once weekly dosing of epoietin alfa is similar to three-times weekly dosing in increasing hemoglobin and quality of life Proceedings of the American Society of Clinical Oncology 18 1999 574A
35. R.S. Gelman S.G. Taylor Cyclophosphamide, methotrexate and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer. The elimination of age trends in toxicity by using doses based on creatinine clearance J Clin Oncol 2 1984 1406 1414
36. P.S. Gill B.M. Espina F. Muggia Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin J Clin Oncol 13 1995 996 1003
37. J. Glaspy R. Bukoswski D. Steinberg Impact of therapy with epoietin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice J Clin Oncol 15 1997 1218 1234
38. J.E. Godwin K.J. Kopecky D.R. Head A double-blind placebo-controlled trial of granulocyte colony-stimulating factor for elderly patients with previously untreated acute myelogenous leukemia: A Southwest Oncology Group Study Blood 91 1998 3607 3615
39. H. Gomez L. Mas L. Casanova Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: Identification of two age subgroups with differing hematologic toxicity J Clin Oncol 16 1998 2352 2358
40. R. Greil Prognosis and management strategies of lymphatic neoplasia in the elderly Oncology 55 1998 189 217
41. W.E. Haley L.A. Ehrbar R.S. Schonwetter Family caregiving issues L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 805 812
42. Y.A. Hannun Apoptosis and the dilemma of cancer chemotherapy Blood 89 1997 1845 1853
43. F.L. Iber P.A. Murphy E.S. Connor Age-related changes in the gastrointestinal system Drugs Aging 5 1994 34 48
44. N. Ibrahim A. Buzdar D. Frye Should age be a determinant factor in treating breast cancer patients with combination chemotherapy? Proceedings of the American Society of Clinical Oncology 12 1993 68
45. S.K. Inoyue P.N. Peduzzi J.T. Robison Importance of functional measures in predicting mortality among older hospitalized patients JAMA 279 1998 1187 1193
46. G.J. Izaks R.G. Westendorp D.L. Knook The definition of anemia in the older person JAMA 281 1999 1714 1717
47. G. Kimmick R. Fleming H. Muss Cancer chemotherapy in older adults: A tolerability perspective Drugs Aging 10 1997 34 49
48. P.E. Kintzel R.T. Dorr Anticancer drug renal toxicity and elimination: Dosing guidelines for altered renal function Cancer Treat Rev 21 1995 33 64
49. S.S. Legha R.S. Benjamin B. Mackay Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion Ann Intern Med 96 1982 133 139
50. A.S. Levey J.P. Bosch J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation Ann Intern Med 130 1999 461 470
51. D.A. Lipschitz Age-related decline in hemopoietic reserve capacity Semin Oncol 22 suppl 1 1995 3 6
52. B. Lowenberg M.A. Boogaerts S.M.G.J. Daenen Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction. Therapy of acute myelogenous leukemia J Clin Oncol 15 1997 3496 3506
53. G.H. Lyman N. Kuderer J. Greene The economics of febrile neutropenia: Implications for the use of colony-stimulating factors Eur J Cancer 34 1998 1857 1864
54. K. Manton A longitudinal study of functional change and mortality in the United States Journal of Gerontology 43 1988 S153 S161
55. E.R. Marcantonio L. Goldman E.J. Orav The association of intraoperative factors with the development of postoperative delirium Am J Med 105 1998 380 384
56. R.M. Meyer G.P. Browman M.L. Samosh Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma J Clin Oncol 13 1995 2386 2393
57. S. Monfardini L. Ferrucci L. Fratino Validation of a multidimensional evaluation scale for use in elderly cancer patients Cancer 77 1996 395 401
58. S.C. Montamat B.J. Cusack R.E. Vestal Management of drug therapy in the elderly N Engl J Med 321 1989 303 309
59. L.C. Moscinski Hemopoiesis and aging L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1999 Harwood Academic Publishers Amsterdam 399 412
60. J.A. Moscow E. Schneider K.H. Cowan Multidrug resistance H.M. Pinedo D.L. Longo B.A. Chabner Cancer Chemotherapy and Biological Response Modifiers, Annual 16 1996 Elsevier Science BV New York 111 131
61. P. Narain L.Z. Rubenstein D. Wieland Predictors of immediate and 6 months outcome in hospitalized elderly patients: The importance of functional status J Am Geriatr Soc 36 1988 775 783
62. P.A. Newcomb P.P. Carbone Cancer treatment and age: Patient perspectives J Natl Cancer Inst 85 1993 1580 1584
63. S.E. O'Reilly J.M. Connors S. Howdle In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: Results of a Phase II study of P/DOCE chemotherapy J Clin Oncol 11 1993 2250 2257
64. S.E. O'Reilly J.M. Connors N. Macpherson Malignant lymphomas in the elderly Clin Geriatr Med 13 1997 251 264
65. M. Ogawa Hematopoiesis J Allergy Clin Immunol 94 1994 645 650
66. J.F. Piccirillo A.R. Feinstein Clinical symptoms and comorbidity: Significance for the prognostic classification of cancer Cancer 77 1996 834 842
67. L. Pierelli A. Perillo S. Greggi Erythropoietin addition to granulocyte-colony stimulating factor abrogates life-threatening neutropenia and increases peripheral blood progenitor-cell mobilization after epirubicin, paclitaxel and cisplatin in combination chemotherapy J Clin Oncol 17 1999 1288 1296
68. M.J. Ratain R.L. Schilsky K.E. Choi Adaptive control of etoposide administration: Impact of interpatient pharmacodynamic variability Clin Pharmacol Ther 45 1989 226 233
69. O. Rockwell C.S. Hughes K.A. Kennedy Effects of host age on microenvironmental heterogeneity and efficacy of combined modality treatment in solid tumors Int J Radiat Oncol Biol Phys 20 1991 259 263
70. J.M. Rowe J. Andersen J.J. Mazza Phase III randomized-placebo controlled study on granulocyte macrophage colony-stimulating factor (GM-CSF) in adult patients with acute myelogenous leukemia. A Study of the Eastern Cooperative Oncology Group Blood 86 1995 257 263
71. E.H. Rubin J.W. Andersen D.T. Berg Risk factors for high dose cytarabine neurotoxicity: An analysis of a Cancer and Leukemia Group B trial in patients with acute myeloid leukemia J Clin Oncol 10 1992 948 953
72. G.N. Rudd G.A. Hartley R.L. Souhani Persistence of cisplatin-induced interstrand crosslinking in peripheral blood mononuclear cells from elderly and younger individuals Cancer Chemother Pharmacol 35 1995 323 326
73. S.B. Schagen van Dam F.S.A.M. M.J. Muller Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 1999 640 650
74. C.A. Schiffer Hematopoietic growth factors as adjuncts to the treatment of acute myelogenous leukemia Blood 88 1996 3675 3685
75. W. Shank L. Balducci Recombinant hemopoietic growth factors: Comparative hemopoietic response in younger and older subjects J Am Geriatr Soc 40 1992 151 154
76. J.H. Silber M. Fridman Di Paola R.S. First-cycle blood counts and subsequent neutropenia, dose reduction or delay in early stage breast cancer therapy J Clin Oncol 16 1998 2392 2400
77. P. Sonneveld M. de Ridder van der Lelie H. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP vs CNOP chemotherapy J Clin Oncol 13 1995 2530 2539
78. E.A. Sotaniemi A.J. Arranto O. Pelkonen Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions Clin Pharmacol Ther 61 1997 331 339
79. G. Stanta Morbid anatomy of aging L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 229 235
80. B.N. Stein N.J. Petrelli H.O. Douglass Age and sex are independent predictors of 5-fluorouracil toxicity Cancer 75 1995 11 17
81. R.M. Stone D.T. Berg S.L. George Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patiens with primary acute myelogenous leukemia N Engl J Med 332 1995 1671 1677
82. S.M. Swain F.S. Whaley M.C. Gerber Cardioprotection with dexarosozane for doxorubicin-containing therapy in advanced breast cancer J Clin Oncol 15 1997 1318 1332
83. K.D. Tew M. Calvin B.A. Chabner Alkylating agents B.A. Chabner Longo D.L. Cancer Chemotherapy and Biotherapy 1996 Lippincott-Raven Philadelphia 297 332
84. J.T. Thigpen Ovarian cancer in the older patient L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 721 732
85. U. Tirelli D. Errante Van Glabbeke M. CHOP is the standard regimen in patients ≥ 70 years of age with intermediate grade and high grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative study J Clin Oncol 16 1998 27 34
86. C.L. Willman The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Leukemia Research Program Semin Hematol 34 suppl 5 1997 25 33
87. H.A. Wynne L.H. Cope O.F.W. James The effect of age and frailty upon acetanilide clearance Age Ageing 18 1989 415 418
88. Van Spronsen D.J. M.L. Janssen-Haijnen W.P. Breed Prevalence of comorbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993–1996 Ann Hematol 78 1999 315 319
89. R.E. Vestal Aging and pharmacology Cancer 80 1997 1302 1310
90. C.H. Vinograd M.B. Gerety M. Chung Screening for frailty: Criteria and predictors of outcome J Am Geriatr Soc 39 1991 778 784
91. W.A. Young F.A. Greco J.P. Greer Aggressive non-Hodgkin's lymphomas in the elderly: An effective well tolerated treatment regimen containing extended schedule etoposide J Natl Cancer Inst 86 1994 1346 1347
92. V. Zagonel A. Pinto S. Monfardini Strategies to prevent chemotherapy-related toxicity in the older person L. Balducci G.H. Lyman Ershler W.B. Comprehensive Geriatric Oncology 1998 Harwood Academic Publishers Amsterdam 481 500
93. P.G. Zinzani S. Storti A. Zaccaria Elderly aggressive histology non-Hodgkin's lymphoma: First line VNCOP-B regimen: Experience on 350 patients Blood 94 1999 33 38